Anthocyanins might regulate FKBP52 to prevent Alzheimer's disease based on the structure variation of FKBP52, especially the purple anthocyanins C3G and M3G. This evidence concerns the gene FKBP4 and early-onset autosomal dominant Alzheimer disease.